NCT02490501View on ClinicalTrials.gov

Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2020

Study Completion Date

May 31, 2025

Conditions
Spinal Cord Injury
Interventions
PROCEDURE

SC0806 and rehabilitation

OTHER

Rehabilitation only

Trial Locations (1)

Unknown

Karolinska University Hospital and RSS, Stockholm

Sponsors

Lead Sponsor

BioArctic AB
All Listed Sponsors
collaborator

European Commission

OTHER

lead

BioArctic AB

INDUSTRY

NCT02490501 - Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects | Biotech Hunter | Biotech Hunter